Name
OÜ BioAnalys
Registry code
10665321
VAT number
EE100668342
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
06.06.2000 (24)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
46462 - Wholesale of medical appliances and surgical and orthopaedic instruments and devices
621 964 €
28 554 €
5%
1 599 €
(estimate is approximate)
428 832 €
4
Submitted
No tax arrears
7%
6%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Kaisa Jõks 25.03.1991 (33) | 100% - 2 556.00 EUR | Board member | Member of a higher management body, i.e. board member or supervisory board member | |
| Priit Kippasto 04.10.1970 (54) | - | - | - | Founder |
| Toomas Jõks 14.04.1969 (55) | - | - | - | Founder |
| 2019 29.06.2020 | 2020 30.06.2021 | 2021 30.06.2022 | 2022 06.06.2023 | 2023 26.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 187 953 € | 580 139 € | 596 185 € | 561 397 € | 621 964 € |
| Net profit (loss) for the period | 11 642 € | 84 455 € | 68 564 € | 97 078 € | 28 554 € |
| Profit Margin | 6% | 15% | 12% | 17% | 5% |
| Current Assets | 64 257 € | 123 914 € | 179 728 € | 275 814 € | 229 624 € |
| Fixed Assets | 127 000 € | 144 553 € | 142 000 € | 142 000 € | 286 187 € |
| Total Assets | 191 257 € | 268 467 € | 321 728 € | 417 814 € | 515 811 € |
| Current Liabilities | 35 046 € | 17 073 € | 7 584 € | 12 866 € | 86 979 € |
| Non Current Liabilities | 0 € | 10 681 € | 4 812 € | 3 472 € | 0 € |
| Total Liabilities | - | 27 754 € | 12 396 € | 16 338 € | - |
| Share Capital | - | - | - | - | - |
| Equity | 156 211 € | 240 713 € | 309 332 € | 401 476 € | 428 832 € |
| Employees | 4 | 4 | 3 | 3 | 4 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 272 654.87 € | 53 817.41 € | 13 000.41 € | 4 |
| 2023 Q4 | 251 148.24 € | 15 830.02 € | 8 210.11 € | 4 |
| 2023 Q3 | 282 986.62 € | 28 489.43 € | 9 382.65 € | 4 |
| 2023 Q2 | 180 213.58 € | 30 856.74 € | 8 566.13 € | 4 |
| 2023 Q1 | 267 597.07 € | 21 228.36 € | 7 184.41 € | 4 |
| 2022 Q4 | 326 506.13 € | 51 204.31 € | 8 292.6 € | 3 |
| 2022 Q3 | 164 791.04 € | 8 611.05 € | 4 113.74 € | 3 |
| 2022 Q2 | 181 798.05 € | 12 000.6 € | 4 233.8 € | 3 |
| 2022 Q1 | 294 942.26 € | 11 169.09 € | 4 065.36 € | 3 |
| 2021 Q4 | 208 733 € | 10 906.27 € | 4 695.86 € | 3 |
| 2021 Q3 | 261 741.46 € | 20 138.14 € | 3 982.36 € | 3 |
| 2021 Q2 | 237 853.94 € | 10 296.29 € | 5 787.52 € | 4 |
| 2021 Q1 | 243 766.45 € | 15 819.57 € | 8 940.39 € | 4 |
| 2020 Q4 | 276 402.33 € | 17 152.62 € | 6 649.38 € | 4 |
| 2020 Q3 | 203 400.04 € | 12 170.74 € | 6 380.56 € | 4 |
| 2020 Q2 | 329 407.93 € | 30 520.42 € | 5 072.49 € | 4 |
| 2020 Q1 | 94 912.83 € | 9 575.53 € | 6 325.1 € | 4 |
